- Apr 1, 2014

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays

Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.

Can Fam Physician. 2014 Apr;60(4):324-33.

PMID: 24733321 Free PMC article. Review.

See All

Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care ...

Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators Khan AA, AbuAlrob H, Al-Alwani H, et al. Osteoporos Int. 2023 Ju

To Break or Not to Break (Again): Is That the Question?

Kherani RB, Singh S. CRAJ. 2022;32(3):1 2 * Posted with permission from publisher

The role of osteoanabolic agents in the management of patients with osteoporosis

McClung MR, Rothman MS , Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL. Postgrad Med. 2022 Aug;134(6):541-551. doi: 10.1080/00325481.2022.2069582. Epub 2022 May 30. PMID: 35635798 Review.

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays

Related Posts